The following pharma and tech companies are set to begin public trading in Oct. 2020. Initial Public Offerings, or IPOs, are occurring in several organizations this fall in software and data management as well as the biotech and pharmaceuticals sectors.
Oncorus IPO date and price details
Oncorus (ONCR) plans to begin trading at a price between $14 and $16 on Oct. 2, seeking an $87 million IPO. They develop viral immunotherapies to treat cancer.
Oncorus was founded to produce oncolytic virotherapy. It seeks public capital market funding to “advance its pipeline through and into clinical trials”.
Immunome, Inc. IPO date and price details
Datto IPO date and price details
A firm IPO date is not yet known, but the cloud backup specialist Datto filed its IPO documents Sept. 29. It will be listed under “MSP” when it joins the public market.
Pulmonx Corp. IPO date and price details
A medical technology company specializing in treatments for patients with severe emphysema, Pulmonx Corp., is going public on Oct. 1. Its 10 million shares are set to begin trading at $19 per share.
C4 Therapeutics, Inc. IPO date and price details
The biopharmaceutical company C4 Therapeutics expects to price on Oct. 1. Their specialty is the development of “small molecule protein degraders to treat cancer.” The NASDAQ symbol is CCCC and its starting price is set at $16-$18 each for 8.8 million shares.
AZIYO Biologics, Inc. IPO date and price details
McAfee IPO date and price details
The cybersecurity company McAfee, under the symbol MCFE, has filed for an IPO but has no set date or price range yet. The company registered to raise up to $100 million, with underwriters including Morgan Stanley, Goldman Sachs, and Citigroup.
Airbnb IPO date and price details
The rental company Airbnb has stated its intent to go public in 2020 despite tourism industry struggles due to the coronavirus. It announced in August that it expected its IPO to happen later this year.
Data seems to indicate that Airbnb is rebounding well. The Wall Street Journal recently reported that it “has recovered to roughly pre-pandemic levels worldwide and has exceeded those levels in the U.S.”
Palantir Technologies IPO date and price details
Palantir Technologies actually debuted on the NYSE on Sept. 30. It was initially listed at $10.00 a share under the ticker symbol “PLTR.” It went public with a direct listing rather than an IPO, not relying on underwriters for demand or pricing.